trial

Integrated Metacognitive Therapy in First Episode Psychosis

NCTId NCT02131116
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 20 (actual)
Sponsored by Indiana University
Primary completion 2016-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
20 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2014-05
Primary completion
2016-12
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
Integrated Metacognitive Therapy

Sponsors

Indiana UniversityLead Sponsor

Sites

2 total
Indianapolis, United StatesIndianapolis, United States

Facts & assertions

4 sourced
Enrollment
20
Phase
NA
Primary Completion Date
2016-12
Status
COMPLETED
relationships
The graph out of here
drug
Integrated Metacognitive Therapy
drug
lead_sponsor
Indiana University
company
indication
Schizophreniform Disorder
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication